CD40 Ligand Antikörper (AA 101-203)
CD40LG
Reaktivität: Human
WB, ELISA
Wirt: Maus
Monoclonal
2E2
unconjugated
-
-
Target
Alle CD40 Ligand (CD40LG) Antikörper anzeigen
-
CD40 Ligand (CD40LG)
-
Bindungsspezifität
-
AA 101-203
-
Reaktivität
-
Human
-
Wirt
-
Maus
-
Klonalität
-
Monoklonal
-
Konjugat
-
Dieser CD40 Ligand Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), ELISA
-
Verwendungszweck
-
Mouse monoclonal antibody raised against a partial recombinant CD40LG.
-
Sequenz
-
NKEETKKENS FEMQKGDQNP QIAAHVISEA SSKTTSVLQW AEKGYYTMSN NLVTLENGKQ LTVKRQGLYY IYAQVTFCSN REASSQAPFI ASLCLKSPGR FER
-
Kreuzreaktivität
-
Human
-
Produktmerkmale
-
Antibody Reactive Against Recombinant Protein.
-
Immunogen
-
CD40LG (NP_000065, 101 a.a. ~ 203 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Klon
-
2E2
-
Isotyp
-
IgG2b
-
Top Product
-
Discover our top product CD40LG Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Buffer
-
In 1x PBS, pH 7.4
-
Handhabung
-
Aliquot to avoid repeated freezing and thawing.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Target
-
CD40 Ligand (CD40LG)
-
Andere Bezeichnung
-
CD40LG (CD40LG Produkte)
-
Synonyme
-
CD154 antikoerper, cd40l antikoerper, CD40L antikoerper, HIGM1 antikoerper, IGM antikoerper, IMD3 antikoerper, T-BAM antikoerper, TNFSF5 antikoerper, TRAP antikoerper, gp39 antikoerper, hCD40L antikoerper, CD40-L antikoerper, Cd40l antikoerper, Ly-62 antikoerper, Ly62 antikoerper, Tnfsf5 antikoerper, CD40 ligand antikoerper, TNF superfamily member 5 antikoerper, CD40LG antikoerper, cd40l antikoerper, Cd40lg antikoerper
-
Hintergrund
-
Full Gene Name: CD40 ligand
Synonyms: CD154,CD40L,HIGM1,IGM,IMD3,T-BAM,TNFSF5,TRAP,gp39,hCD40L
-
Gen-ID
-
959
-
NCBI Accession
-
NM_000074
-
Pathways
-
NF-kappaB Signalweg, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-